investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

The Changing Tides of Cryder Capital: Analyzing Q4 2022 13F Holdings

Ava Hoppe | 30 April, 2023

Cryder Capital Partners LLP is a global investment firm that specializes in a wide range of investment strategies, including private equity, public equity, and real estate. The firm recently released its Q4 2022 13F holdings, which shows a comparison between the Q4 2021 and Q4 2022 holdings. As an investor, it is essential to understand the fluctuations in holdings and how it can impact the long-term prospects of the fund.

In this blog post, we will analyze the changes in the holdings of Cryder Capital Q4 2022 and Q4 2021 13F holdings, and how it can offer valuable insights into the investment philosophy of the firm.

Introduction

Cryder Capital Partners LLP, founded by Jim and Kevin Cryder, is a global investment firm that manages a diverse portfolio of assets totaling approximately $5 billion in assets under management. The firm's investment philosophy is grounded in fundamental research, long-term investments, and disciplined risk management.

The Securities and Exchange Commission requires institutional investment managers with assets over $100 million to file a 13F form every quarter. The 13F form indicates an institutional investment manager's holdings, including the issuer name, number of shares held, and the total value of the investment.

Main Body

The Q4 2022 13F holdings of Cryder Capital show a total of ten holdings with a total market value of $1.345 billion. One of the primary holdings of the fund is HCA Healthcare Inc, a leading healthcare provider in the United States. During the Q4 2022 period, Cryder Capital maintained its holding of 932,529 shares worth $223.7 million, representing 16.6% of the portfolio.

Another significant holding in Cryder Capital's portfolio is Thermo Fisher Scientific. The firm increased its holding by 11.6%, holding 394,681 shares worth $217.3 million. This move represents Cryder's belief in the long-term potential of the biotechnology sector and Thermo Fisher's market leadership position within the industry.

Charter Communications Inc N is another notable holding in Cryder Capital's portfolio, with 622,091 shares worth $210.9 million. Cryder trimmed its holding by 2.2% compared to Q4 2021. Charter Communications Inc N is the second-largest cable television company in the US, and the move to reduce its holding within the company indicates the firm's cautious approach towards the cable industry's long-term prospects.

Microsoft Corp and Alphabet Inc, two of the world's most valuable technology companies, are major holdings in Cryder Capital's portfolio. Cryder maintained its holding of 837,444 shares of Microsoft Corp worth $200.8 million and 1,961,083 shares of Alphabet Inc worth $174 million. These investments reflect the firm's belief in the long-term prospects of the technology sector and the dominance of these companies within their respective markets.

Cryder Capital's investment in Blackstone Inc is another notable holding, with the firm holding 2,115,349 shares worth $156.9 million. Cryder increased its stake in the company by 4.4% compared to Q4 2021. Blackstone's leadership position within the alternative asset management industry can provide a steady stream of return to Cryder's portfolio.

Visa Inc, Mastcard Incorporated, Meta Platforms Inc, and Alibaba Group Holding Ltd are the remaining holdings in Cryder Capital's Q4 2022 13F holdings. Overall, these constitute 11.3% of the portfolio and are indicative of the firm's investments in the fintech, social media, and e-commerce sectors.

Conclusion

Investors can gain valuable insights into Cryder Capital's investment philosophy by analyzing its Q4 2022 13F holdings. The data indicates the firm's long-term strategy, focus on risk management, and diversified portfolio. By investing in dominant players within various industries, the company can mitigate risk and provide a steady stream of returns to its investors.

However, the changes in holdings within the cable industry and the increased investment in biotechnology and alternative asset management illustrate the cautious approach taken by the firm's management. Overall, Cryder Capital's Q4 2022 13F holdings provide a glimpse into the firm's investment strategy and the sectors it believes have strong growth prospects in the coming years.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.